Concord Wealth Partners Axsome Therapeutics, Inc. Transaction History
Concord Wealth Partners
- $673 Million
- Q2 2025
A detailed history of Concord Wealth Partners transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 1 shares of AXSM stock, worth $104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$104% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
404Shares Held
36.5MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$404 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$344 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$305 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$176 Million8.66% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$103 Million0.01% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.47B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...